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CC BY-NC-ND license (http://creativeAbstract NOTCH plays a role in regulating stem cell function and fate decision. It is involved
in tooth development and injury repair. Information regarding NOTCH expression in human
dental root apical papilla (AP) and its residing stem cells (SCAP) is limited. Here we investi-
gated the expression of NOTCH3, its ligand JAG1, and mesenchymal stem cell markers
CD146 and STRO-1 in the AP or in the primary cultures of SCAP isolated from AP. Our in situ
immunostaining showed that in the AP NOTCH3 and CD146 were co-expressed and associated
with blood vessels having NOTCH3 located more peripherally. In cultured SCAP, NOTCH3 and
JAG1 were co-expressed. Flow cytometry analysis showed that 7%, 16% and 98% of the isolated
SCAP were positive for NOTCH3, STRO-1 and CD146, respectively with a rare 1.5% subpopula-
tion of SCAP co-expressing all three markers. The expression level of NOTCH3 reduced when
SCAP underwent osteogenic differentiation. Our findings are the first step towards defining
the regulatory role of NOTCH3 in SCAP fate decision.
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Since the discovery of stem cells from apical papilla
(SCAP), new clinical treatment concepts have emerged. A
clinical regenerative protocol has been proposed based on
some research studies and many clinical case reports.1e5
The theory behind this protocol is that SCAP in the api-
cal papilla may be induced to regenerate damaged or lost
pulp tissue in the canal space.6e8 This possibility is further
supported by the capacity of SCAP to regenerate pulp-
dentin-like tissues in vivo in animal models.6,9 However,
despite such clinical endeavors to practice regenerative
treatments, the understanding of the biology of SCAP is
still limited.
NOTCH signaling pathway plays a key role in the
development and morphogenesis of different organs and
tissues in various species. It promotes or suppresses cell
proliferation, initiates or inhibits cell differentiation and
determines the fate of different types of stem cells.10
There are four NOTCH receptors (NOTCH1e4), which are
activated by direct contact with their membrane-bound
ligands (JAGGED (JAG) 1, JAG2, Delta-like (DLL) 1, DLL3
and DLL4) on neighboring cells. Upon activation of NOTCH
receptors, enzymatic activities are triggered resulting in
the cleavage of NOTCH intracellular domain (NICD), which
is then translocated into the nucleus to activate the
transcription of target genes, such as HEY1 and HEY2.10,11
NOTCH signaling pathway is also believed to be involved
and play an important role in the process of tooth
development and pulp regeneration and repair after
injury.12e14 NOTCH3 and its ligand JAG1 are upregulated
during tooth development in the vicinity of blood vessels
and in the subodontoblast layer, but not in odontoblasts.
Similar expression pattern was found in pulp tissue un-
dergoing repair and regeneration after pulp exposure and
capping.12,15,16 Interestingly, NOTCH3 is expressed in the
cervical loop (stem cell niche) of continuously erupting
teeth (mouse incisors and vole molars), suggesting its
possible role in maintaining the undifferentiated state of
cells within that niche.13
Little is known regarding the expression of NOTCH3 and
its ligand JAG1 in apical papilla (AP) and SCAP. The aim of
this study was to investigate whether and where NOTCH3 is
expressed in AP and its expression along with JAG1 in
cultured SCAP, as well as its co-expression with mesen-
chymal stem cell markers CD146 and STRO-1.Material and methods
Sample collection
This study was approved by the Human Research Ethics
Committee of United Arab Emirates University (#11/10) and
Boston University Medical Institutional Review Board (#H-
28882). Freshly extracted, intact human teeth were ob-
tained from 10 to 24 years old consented healthy patients
(n Z 5). The teeth were caries-free and had incompletely
formed root apices. The root apical papillae were micro-
dissected from extracted teeth and SCAP were isolated and
cultured as described below based on a previous report.6Immunohistochemical staining of apical papillae
Apical papillae were obtained as mentioned above and
processed for cryosectioning; 8 mm-thick sections were
fixed with cold acetone at 20 C for 15 min, washed in
PBS, treated with 1.5% hydrogen peroxide for 30 min and
blocked with 2.5% normal horse serum (Vectastain Elite ABC
kit; Vector laboratories) for 1 h. Tissue sections were then
incubated with mouse monoclonal anti-NOTCH3 antibodies
(dilution 1:100, Abcam, USA) for 1 h at room temperature,
followed by washing and incubation with biotinylated anti-
mouse immunoglobulin G (secondary antibody) for another
1 h. After washing, avidin-peroxidase complex was added
and incubated for 30 min, followed by washing and the
addition of peroxidase substrate solution for 5 min. Sec-
tions were counterstained with hematoxylin solution
(Sigma, USA). Negative control slides were prepared in
parallel without adding the primary antibody.
For immunofluorescence staining, frozen sections of AP
were fixed with cold acetone at 20 C for 15 min, washed
and blocked for 1 h. Sections were then incubated with
primary antibodies: NOTCH3 (dilution 1:100, Abcam, USA)
and CD146 (dilution 1:50, Invitrogen, USA) for 1 h at room
temperature, followed by washing and incubation with the
appropriate fluorophore-conjugated secondary antibodies
for another 1 h.
Isolation and culture of SCAP
The papillae were minced and digested in a physiological
solution containing 3 mg/mL collagenase type I (GIBCO/
Invitrogen) and 4 mg/mL dispase (GIBCO/Invitrogen) for
45 min at 37 C. Isolated cells were then plated in culture
dishes containing alpha-modification of Eagle’s medium
(GIBCO/Invitrogen) supplemented with 10% fetal bovine
serum (GIBCO/Invitrogen), 2 mM L-glutamine (GIBCO/Invi-
trogen), 100 U/mL penicillin and 100 mg/mL streptomycin
(GIBCO/Invitrogen) and incubated in a humidified incubator
(Thermo Scientific) at 37 C in 5% CO2. Once the cells reached
w80% confluence, they were trypsinized and passaged.
Immunocytochemical and immunofluorescence
staining of SCAP
For immunocytochemistry, isolated SCAP of passage 2 were
seeded on sterile coverslips. At 80% confluence, cells were
fixed using 4% paraformaldehyde (PFA) for 30 min, washed
with phosphate-buffered saline (PBS) and permeabilized
with 0.1% Triton-X100 (Sigma, USA). To inhibit endogenous
peroxidase activity, cells on coverslips were incubated in 1%
hydrogen peroxide in PBS for 35min. Nonspecific binding was
blocked by incubating cells in 1% bovine serum albumin (BSA)
containing 0.5% Tween-20 in PBS for 45 min. Cells were then
incubated with goat polyclonal anti-NOTCH3 antibody
(dilution 1:25, clone M-20, Santa Cruz Biotechnology Inc.,
USA) overnight at 4 C. Cells on coverslips were washed with
PBS and then incubated with biotinylated donkey-anti-goat
immunoglobulin G (dilution 1:500, Jackson ImmunoResearch
Laboratories Inc., USA) for 1 h and then were incubated in
extravidin/peroxidase conjugate (dilution 1:1000, Sigma,
USA) for 1 h. The antigeneantibody binding sites were
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minobenzidine tetrahydrochloride (DAB, Sigma, USA).
Negative control slides were prepared in parallel without
adding the primary antibody.
For immunofluorescence staining, SCAP were grown on
chamber slides and they were fixed, when reaching 80%
confluence, in 4% PFA for 30 min, permeabilized, blocked
and incubated with primary antibodies; NOTCH3 (dilution
1:100, Abcam, USA) and JAG1 (dilution 1:100, Santa Cruz
Biotechnology, USA) for 1 h. The samples were subse-
quently incubated with the corresponding secondary anti-
bodies for another 1 h followed by counterstaining with
DAPI (Invitrogen, USA). The samples were then observed
and images recorded under a fluorescence microscope.
Flow cytometry of SCAP
SCAP at passage 3 were grown in a T25 mm flask to reach 80%
confluence. They were harvested, washed with PBS, and
resuspended in PBS containing 2% fetal bovine serum. Con-
jugated mouse IgG1k anti-human monoclonal antibodies
specific for CD146-APC, STRO-1-FITC and NOTCH3-PE or their
corresponding isotype controls were added according to theFig. 1 Detection of NOTCH3 and CD146 in human apical papilla. (
NOTCH3 staining is associated with blood vessels. (B) Staining for N
apical papilla showing blood vessels stained for D) NOTCH3 (green),
DAPI (blue), (H) co-localization of NOTCH3, CD146 and DAPI. Data ar
donors each performed in triplicate.recommended manufacturer concentrations (Biolegend,
USA) for 30minat 4 C.Cellswerewashed and resuspended in
PBS. Flow cytometry was performed on FACSCalibur cytom-
eter (BD Biosciences), and data were analyzed using FlowJo
software (Tree Star Inc., Ashland, OR).
Osteogenic differentiation of SCAP
SCAP were grown to 80% confluence and incubated in
osteogenic differentiation media containing 10 nM dexa-
methasone, 10 mM b-glycerophosphate, 50 mg/mL ascor-
bate phosphate, 10 nM 1,25-dihydroxyvitamin D3, and 10%
FBS (Gibco/Invitrogen USA) for 14 days. SCAP were pro-
cessed and stained for NOTCH3 for flow cytometry analysis
as mentioned above.
Results
Immunohistochemical analysis of the apical papilla
The immunohistochemical staining showed that NOTCH3
expression is associated with blood vessels (Fig. 1).A) Immunohistochemical staining of the apical papilla, showing
OTCH3, (C) control. (DeH) Immunoflourescence staining of the
(E) CD146 (red), (F) co-localization of NOTCH3 and CD146, (G)
e representative of independent experiments of samples from 2
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confirmed the results of the immunohistochemical staining,
and showed that cells in and around the wall of blood vessels
were stained positive for NOTCH3 and CD146 with NOTCH3
located at the outer layer of the vascular vessel wall.
Detection of NOTCH3 in cultured SCAP
Immunocytochemical staining revealed the localization of
NOTCH3 in the nucleus and the cytoplasm of SCAP espe-
cially in the perinuclear region (Fig. 2A,B). Immunofluo-
rescence double-staining showed that NOTCH3 and its
ligand, JAG1 were co-localized in SCAP; NOTCH3 was
detected in the perinuclear area of the cytoplasm and also
in the nucleus, while JAG1 is concentrated in the peri-
nuclear cytoplasm (Fig. 2C,D).
Quantification and characterization of NOTCH3-
expressing subpopulations of SCAP
Flow cytometry analysis showed that 7%, 16% and 98% of the
isolated SCAP were positive for NOTCH3, STRO-1 and
CD146, respectively. All the 7% NOTCH3þ SCAP expressedFig. 2 Expression of NOTCH3 and JAG1 in SCAP at passage 3. (
staining for NOTCH3 in the perinuclear region (indicated by the whit
Immunoflourescence staining of SCAP showing positive staining for N
the perinuclear region and in the nucleus while JAG1 only in the c
showing both NOTCH3 and JAG1 in the same cell. Similar finding i
representative of independent experiments of samples from 3 donCD146, and only 1.5% of the total SCAP population co-
expressed NOTCH3, STRO-1 and CD146 (Fig. 3).
SCAP lose NOTCH3 expression after differentiation
To examine the relationship between SCAP differentiation
and NOTCH3 expression, flow cytometry analysis was per-
formed for SCAP grown in the regular medium or osteogenic
differentiation medium. The flow cytometry results showed
that NOTCH3 expression was detected on SCAP when
cultured in the regular medium while the expression was
absent when cultured in the osteogenic differentiation
medium (Fig. 4).
Discussion
To understand the possible role of NOTCH signaling
pathway in SCAP we undertook the first step by examining
the expression of NOTCH3 and its ligand JAG1. We found
that a subpopulation of SCAP is expressing NOTCH3 (Figs. 2
and 3) similar to recent findings reported by Sun et al.17
These results suggest a possible role of NOTCH3 in regu-
lating SCAP properties and behaviors. Mitsiadis et al foundA, B) Immunocytochemical staining of SCAP, showing positive
e arrow in A) and in the nucleus (yellow arrow head in A). (CeH)
OTCH3 (green) and JAG1 (red). Note that NOTCH3 is located in
ytplasm and perinuclear region. In (CeE), isolated single cells
s in (FeH) when cells are in contact with each other. Data are
ors each performed in triplicate.
Fig. 3 Flow cytometry analysis of SCAP at passage 3. (A) Representative images of SCAP ofw80% confluence before subjected to
flow cytometry. (B) SCAP double staining with NOTCH3 and STRO-1: 7% is expressing NOTCH3, 15.8% expressing STRO-1 and 1.5%
expressing both STRO-1 and NOTCH3. (C) Flow cytometry dot plots showing triple- staining of SCAP for CD146 (red), STRO-1 (purple)
and NOTCH3 (blue). Note the triple positive population of cells are shown in green. Data are representative of 2 experiments
performed in triplicate.
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subodontoblast layer but not in odontoblast.12 In another
study, they found it expressed in the stem cell niche of
cervical loop of mouse incisor, but this expression de-
creases and disappears as the cells leave the niche and
move coronally and start to differentiate into amelo-
blasts.13 They suggest that NOTCH3 could be responsible
for maintaining the cells in their undifferentiated state,
and that once the cells differentiate they lose NOTCH3
expression. Our findings shown in Fig. 4 that SCAP lose
NOTCH3 expression after osteo-induction suggests that
NOTCH3 is associated with less differentiated SCAP. This
indicates that NOTCH3 may play a role in maintaining SCAP
in their undifferentiated state, as is suggested in the
recent studies of SCAP and DPSCs by other in-
vestigators.17,18 However, further experiments are needed
to confirm this possibility and to explore the association of
NOTCH3 with SCAP stemness and differentiation status.STRO-1 and CD146 are considered as early markers of
many types mesenchymal stem cells (MSCs) and it was found
that 82% and 96% of the dental pulp derived colony forming
cells were represented in the STRO-1þ and CD146þ sub-
populations, respectively.19 In addition, it was found that
the STRO-1þ subpopulation demonstrated higher expression
of embryonic and MSCs makers and had a better odontogenic
potential than the STRO-1- subpopulation.20,21 To investi-
gate whether NOTCH3þ SCAP share the expression of STRO-1
and CD146, our flow cytometry analysis showed that 7%, 16%
and 98% of the isolated SCAP were positive for NOTCH3,
STRO-1 and CD146 respectively. The latter two markers
were examined by Sonoyama et al and the respective per-
centage is similar to our findings.6 Our flow cytometry using
triple staining is the first to demonstrate the presence of
these subpopulations of SCAP. While our data indicate that
almost all isolated SCAP expressed CD146, there are 4
distinct different subpopulations: 7% NOTCH3þSTRO1-,
Fig. 4 Flow cytometry analysis of SCAP at passage 3 underwent osteogenesis. (A) Control SCAP expressing NOTCH3; (B) SCAP after
osteogenic differentiation for 14 days losing NOTCH3 expression. Representative data from 2 experiments in triplicate.
266 M. Jamal et al.w16% NOTCH3-STRO-1þ, w75% NOTCH3-STRO-1- and a rare
population of NOTCH3þSTRO-1þ (Fig. 3). Further investiga-
tion is warranted to explore the characteristics of these
subpopulations such as NOTCH3þ SCAP, especially in the
context of regenerative potential, as other MSCs are known
to be heterogeneous containing different subpopulations of
varying regenerative potential.19,20,22
As mentioned earlier, studies have indicated that during
tooth development and after pulp injury, NOTCH3 is upre-
gulated and expressed on the wall of blood vessels.15,16
Lovschall et al found a similar expression pattern and that
NOTCH3 was co-expressed with RGS5, which is one of the
markers for peicytes.15 These findings suggest that those
NOTCH3-expressing cells likely reside in the perivascular
niche and may be of pericyte origin. Our immunohisto-
chemical staining indicates that NOTCH3 expression in
apical papillae is exclusively associated with blood vessels.
The doubled staining (NOTCH3 and CD146) further showed
that both are restricted and co-localized in and around the
vascular walls with NOTCH3 located more in the periphery
(Fig. 1). The reason why we chose CD146 in addition to
NOTCH3 was that 1) all the 7% NOTCHþ SCAP are expressing
CD146, and 2) CD146 is one of the pericyte markers.19,23
This expression pattern of NOTCH3 in SCAP and their
localization on the outer layer of the vascular wall are in
favor of the possibility that NOTCH3þ SCAP is of pericyte
origin in apical papillae.
In NOTCH signaling, its receptors are activated by
binding to one of its ligands on neighboring cells and this
require direct physical contact between two cells.10 We
attempted to identify other subpopulations of SCAP that
provide the ligands to NOTCHþ SCAP. To our surprise, we
found that NOTCH3 and JAG1 were co-localized on the
same cells in culture (Fig. 2CeH). To confirm this finding,
we repeated this immunohistochemical localization with
antibodies from different sources, and the results were
consistent (Data not shown). As mentioned earlier, NOTCH
activation will result in the cleavage of NICD and its
translocation to the nucleus.10,11 Our data showed that
NOTCH3 was also localized in the nucleus (Fig. 2C,F) andthe anti-NOTCH3 antibodies we used were bound to the
intracellular domain. This suggests that the receptor might
have been already activated as it was translocated into the
nucleus. This NOTCH3 activation could be a result of
binding to a ligand (JAG1 or other ligands such as Delta-1)
on adjacent cells; or via a different mechanism from the
classical NOTCH activation mechanism, possibly in a cell-
autonomous NOTCH activation mode, in which both
NOTCH receptor and its ligand are present on the same cell.
The later possibility is supported by the expression of both
NOTCH3 and JAG1 in the same cells, NOTCH3 localization in
the nucleus, and this expression pattern is consistent when
cells are isolated (Fig. 2CeE) or in contact with other cells
(Fig. 2FeH). This mode of activation has been reported in
Drosophila and in vascular smooth muscle cells in pulmo-
nary arteries.11,24Conclusion
Our findings set the basis for further studies to explore
NOTCH3 signaling in SCAP and its role in controlling SCAP
behavior and faith decision. A better understanding of SCAP
biology may help develop clinical strategies to advance
regenerative endodontics.Conflicts of interest
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